Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-24 @ 2:49 PM
NCT ID:
NCT02343159
Eligibility Criteria:
Key Inclusion Criteria:
* The candidate is a DMF-naïve patient
* Have a diagnosis of relapsing forms of MS and satisfy the approved therapeutic indication for DMF
* Have a recent (i.e., within the previous 6 months) complete blood count with results that do not preclude the patient's participation in the study, in the judgment of the Investigator
Key Exclusion Criteria:
* Have comorbid conditions that preclude participation in the study, as determined by the Investigator
* History of severe allergic or anaphylactic reactions or known drug hypersensitivity
* Are participating, planning to participate, or have participated in the Tecfidera QuickStart Program
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02343159
Study Brief:
Protocol Section:
NCT02343159